Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2018 (2018), Article ID 1460283, 3 pages
https://doi.org/10.1155/2018/1460283
Case Report

Septic Pulmonary Emboli and Renal Abscess Caused by Staphylococcus aureus in an HIV-Infected Patient

1Infectious Diseases Service, Hospital Universitario “Dr. José E. González” and Medical School, Universidad Autónoma de Nuevo León, Madero y Gonzalitos S/N, 64460 Monterrey, NL, Mexico
2Department of Internal Medicine, Hospital Universitario “Dr. José E. González” and Medical School, Universidad Autónoma de Nuevo León, Madero y Gonzalitos S/N, 64460 Monterrey, NL, Mexico

Correspondence should be addressed to Adrián Camacho-Ortiz; moc.oohay@dm_ohcamaca

Received 15 November 2017; Revised 18 December 2017; Accepted 19 December 2017; Published 24 January 2018

Academic Editor: Paola Di Carlo

Copyright © 2018 Isaí Medina-Piñón et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Y. Tong, J. S. Davis, E. Eichenberger, T. L. Holland, and V. G. Fowler, “Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management,” Clinical Microbiology Reviews, vol. 28, no. 3, pp. 603–661, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Akova, “Epidemiology of antimicrobial resistance in bloodstream infections,” Virulence, vol. 7, no. 3, pp. 252–266, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Taramasso, P. Tatarelli, and A. Di Biagio, “Bloodstream infections in HIV-infected patients,” Virulence, vol. 7, no. 3, pp. 320–328, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. J. van Hal, S. O. Jensen, V. L. Vaska, B. A. Espedido, D. L. Paterson, and I. B. Gosbell, “Predictors of mortality in Staphylococcus aureus bacteremia,” Clinical Microbiology Reviews, vol. 25, no. 2, pp. 362–386, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Cole and K. Popovich, “Impact of community-associated methicillin resistant Staphylococcus aureus on HIV-infected patients,” Current HIV/AIDS Reports, vol. 10, no. 3, pp. 244–253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. H. Shadyab and N. F. Crum-Cianflone, “Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature,” HIV Medicine, vol. 13, no. 6, pp. 319–332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Boyle-Vavra and R. S. Daum, “Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin,” Laboratory Investigation, vol. 87, no. 1, pp. 3–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Sergi, F. Shen, D. W. Lim et al., “Cardiovascular dysfunction in sepsis at the dawn of emerging mediators,” Biomedicine & Pharmacotherapy, vol. 95, pp. 153–160, 2017. View at Publisher · View at Google Scholar
  9. H. G. Oh, S. I. Cha, K. M. Shin et al., “Risk factors for mortality in patients with septic pulmonary embolism,” Journal of Infection and Chemotherapy, vol. 22, pp. 553–558, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. U. Goswami, J. A. Brenes, G. V. Punjabi, M. M. LeClaire, and D. N. Williams, “Associations and outcomes of septic pulmonary embolism,” Open Respiratory Medicine Journal, vol. 8, no. 1, pp. 28–33, 2014. View at Publisher · View at Google Scholar
  11. A. S. VanEperen and J. J. Segreti, “Empirical therapy in methicillin-resistant Staphylococcus aureus infections: an up-to-date approach,” Journal of Infection and Chemotherapy, vol. 22, no. 6, pp. 351–359, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. E. J. Zasowski, T. D. Trinh, K. C. Claeys et al., “Multicenter observational study of ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bloodstream infections,” Antimicrobial Agents and Chemotherapy, vol. 61, no. 2, pp. e02015–e02016, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Arshad, V. Huang, P. Hartman, M. B. Perri, D. Moreno, and M. J. Zervos, “Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study,” International Journal of Infectious Diseases, vol. 57, pp. 27–31, 2017. View at Publisher · View at Google Scholar · View at Scopus